— Know what they know.
Not Investment Advice
Also trades as: SIGHT.PA (PAR) · $vol 0M

GSGTF OTC

GenSight Biologics S.A.
1W: -11.1% 1M: -11.1% 3M: -11.1% YTD: -57.9% 1Y: -57.9% 3Y: -97.5% 5Y: -98.9%
$0.08
-0.01 (-11.11%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 40 · $13.0M mcap · 169M float · 0.0000% daily turnover

📊 Key Metrics

TTM
$-1M
Revenue
-139.6% YoY
$-30M
Net Income
+38.0% YoY
$-18M
Free Cash Flow
+62.8% YoY
0.0%
Gross Margin
734.5%
Op. Margin
848.8%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE104.0%
ROA-283.5%
ROIC107.2%

Valuation

P/E-1.1
P/B-0.6
EV/EBITDA0.0

Leverage

Debt/Equity-0.38
Current Ratio0.35
Interest Cov.-6.8x

Quality Scores

Piotroski F2/9
Altman Z—
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms